Cliff Asness's DMAC Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 11,287 shares of DiaMedica Therapeutics Inc. (DMAC) worth $76,413, representing 0.00% of the portfolio. First purchased in 2025-Q3, this short-term holding has been held for 3 quarters.
Based on 13F filings, Cliff Asness has maintained this position in DMAC for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 8,314 shares. Largest reduction occurred in Q1 2026, reducing 24,478 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's DiaMedica Therapeutics (DMAC) Holding Value Over Time
Track share changes against reported price movement
Quarterly DiaMedica Therapeutics (DMAC) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -24,478 | Reduce 68.44% | 11,287 | $6.77 |
| Q4 2025 | +8,314 | Add 30.29% | 35,765 | $7.96 |
| Q3 2025 | +27,451 | New Buy | 27,451 | $6.87 |
Cliff Asness's DiaMedica Therapeutics Investment FAQs
Cliff Asness first purchased DiaMedica Therapeutics Inc. (DMAC) in Q3 2025, acquiring 27,451 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held DiaMedica Therapeutics Inc. (DMAC) for 3 quarters since Q3 2025.
Cliff Asness's largest addition to DiaMedica Therapeutics Inc. (DMAC) was in Q3 2025, adding 27,451 shares worth $188,588.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 11,287 shares of DiaMedica Therapeutics Inc. (DMAC), valued at approximately $76,413.
As of the Q1 2026 filing, DiaMedica Therapeutics Inc. (DMAC) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in DiaMedica Therapeutics Inc. (DMAC) was 35,765 shares, as reported at the end of Q4 2025.